当前位置： SCI文献检索 > ADVANCES IN THERAPY期刊下所有文献 > Switching from depot antipsychotics to risperidone: results of a study of chronic schizophrenia. The Schizophrenia Treatment & Assessment Group.

Switching from depot antipsychotics to risperidone: results of a study of chronic schizophrenia. The Schizophrenia Treatment & Assessment Group.

Abstract：

:Designed to provide information about patients with schizophrenia who switch from depot neuroleptics to the oral, atypical antipsychotic risperidone, this multicenter observational study enrolled patients who wished to stop the depot, had an unsatisfactory response, or experienced unacceptable side effects. Individuals remained on depot medication for 4 weeks and then received risperidone monotherapy for 3 months. Of the 143 patients who entered the study, 130 received risperidone, 109 completed the initial 16-week study, and 88 entered an optional 12-week follow-up. Symptoms and side effects did not change significantly during the depot phase (mean Positive and Negative Syndrome Scale [PANSS] score 72.2 at baseline, 71.6 at visit 2), but PANSS scores, global assessment of functioning, parkinsonism, and dyskinesia improved significantly during the risperidone phase (mean PANSS score decreased from 71.6 to 55.5 after 3 months). The number of contacts with healthcare professionals fell significantly during the risperidone phase; in addition, symptomatic improvements were maintained during follow-up, and movement disorders continued to decrease significantly. The investigators considered that 81% of patients had switched successfully. Patient acceptance of risperidone was significantly higher than for depot medication (83% vs 23%; P < .001), and 65% considered risperidone better than their previous treatment. Indications for depot medication should be reviewed, and patients may benefit from a switch to risperidone.

journal_name

Adv Ther

journal_title

Advances in therapy

authors

Desai NM,Huq Z,Martin SD,McDonald G

subject

Has Abstract

pub_date

1999-03-01 00:00:00

pages

78-88

issue

2

eissn

0741-238X

issn

1865-8652

pii

164

journal_volume

16

pub_type

临床试验,杂志文章,多中心研究

相关文献

ADVANCES IN THERAPY文献大全
  • Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.

    abstract：INTRODUCTION:Diuretic responsiveness in patients with chronic heart failure (CHF) is better assessed by urine production per unit diuretic dose than by the absolute urine output or diuretic dose. Diuretic resistance arises over time when the plateau rate of sodium and water excretion is reached prior to optimal fluid e...

    journal_title：Advances in therapy

    pub_type： 杂志文章,随机对照试验

    doi：10.1007/s12325-015-0254-9

    authors： Paterna S,Di Gaudio F,La Rocca V,Balistreri F,Greco M,Torres D,Lupo U,Rizzo G,di Pasquale P,Indelicato S,Cuttitta F,Butler J,Parrinello G

    更新日期：2015-10-01 00:00:00

  • Long-term effects of beraprost sodium on arteriosclerosis obliterans: a single-center retrospective study of Japanese patients.

    abstract：INTRODUCTION:Arteriosclerosis obliterans (ASO) causes ischemic symptoms of the lower limbs, reducing quality of life (QOL), and has a poor prognosis. Early diagnosis and treatment are necessary. In this study, the effects of long-term administration of beraprost sodium (beraprost) to treat ASO were investigated. METHO...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-013-0030-7

    authors： Arai T

    更新日期：2013-05-01 00:00:00

  • Self-expandable metallic stents for malignant gastric outlet obstruction.

    abstract：:Duodenal self-expandable metal stents (SEMS) are designed for palliation and prompt relief of malignant gastric outlet obstruction (GOO). This mini-invasive endoscopic treatment is preferable to surgery due to its lower morbidity and mortality, shorter hospitalization, and earlier symptoms relief; furthermore endoscop...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/s12325-010-0061-2

    authors： Boškoski I,Tringali A,Familiari P,Mutignani M,Costamagna G

    更新日期：2010-10-01 00:00:00

  • Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review.

    abstract：:Polycystic ovary syndrome (PCOS) affects 6-10% of women and could be considered one of the most common endocrine alterations in women of reproductive age. The syndrome is characterized by several hormonal and metabolic alterations, including insulin resistance and hyperandrogenism, which play a severe detrimental role...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/s12325-018-0810-1

    authors： Reyes-Muñoz E,Sathyapalan T,Rossetti P,Shah M,Long M,Buscema M,Valenti G,La Rosa VL,Cianci S,Vitale SG

    更新日期：2018-11-01 00:00:00

  • Efficacy and tolerability of Hypericum extract STW 3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial.

    abstract：:In this double-blind, randomized, placebo-controlled, prospective study, the clinical efficacy and tolerability of oral Hypericum extract STW 3-VI (Laif) 900 mg once daily was compared with that of placebo. A total of 140 outpatients (94 women; 46 men) with moderate depressive disorders and a 17-item Hamilton Depressi...

    journal_title：Advances in therapy

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1007/BF02850158

    authors： Uebelhack R,Gruenwald J,Graubaum HJ,Busch R

    更新日期：2004-07-01 00:00:00

  • Prognosis and treatment outcome in patients with acute myeloid leukemia with t(8;21)(q22;q22).

    abstract：:Patients with acute myeloid leukemia (AML) with the t(8;21) karyotype generally have a favorable clinical course, but key prognostic factors remain poorly defined. This study was conducted to determine the prognoses and treatment outcomes of patients with AML with this unique cytogenetic change. A total of 22 patients...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/BF02849984

    authors： Chen CC,Gau JP,Yu YB,Lu CH,Lee KD,You JY

    更新日期：2007-07-01 00:00:00

  • Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics.

    abstract：INTRODUCTION:Aripiprazole and olanzapine are atypical antipsychotics. Both drugs can induce metabolic changes; however, the metabolic side effects produced by aripiprazole are more benign. The aim of the study was to evaluate if aripiprazole and olanzapine alter prolactin levels, lipid and glucose metabolism and hepati...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-020-01566-w

    authors： Koller D,Almenara S,Mejía G,Saiz-Rodríguez M,Zubiaur P,Román M,Ochoa D,Navares-Gómez M,Santos-Molina E,Pintos-Sánchez E,Abad-Santos F

    更新日期：2020-12-05 00:00:00

  • A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus.

    abstract：INTRODUCTION:Comparisons between brand and biosimilar basal insulin in hospitalized patients are lacking. We aimed to compare the efficacy and safety of brand insulin glargine vs. biosimilar insulin glargine in non-critical hospitalized patients with type 2 diabetes mellitus (T2DM). METHODS:This retrospective study wa...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-019-00922-9

    authors： Hu X,Zhang L,Dong C,Dong Y,Jiang J,Gao W

    更新日期：2019-05-01 00:00:00

  • Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.

    abstract：:Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice. While randomized clinical trials (RCTs) are the "gold standard" for evaluating the safety and efficacy of new therapeutic agents, necessarily strict inclusion and exclusion criteria mean that tr...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/s12325-018-0805-y

    authors： Blonde L,Khunti K,Harris SB,Meizinger C,Skolnik NS

    更新日期：2018-11-01 00:00:00

  • Assessing thrombosis risk in patients with idiopathic, diabetic, and postsurgical gastroparesis.

    abstract：:Patients with severe gastrointestinal motility disorders are often found to have intravenous access clots or deep venous thrombosis. It has previously been reported that many patients who have intravenous access thrombosis have concomitant thrombotic risk factors. In this study, the goal was to determine the underlyin...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/BF02850315

    authors： Lobrano A,Blanchard K,Rock W,Johnson W,Schmieg B,Borman K,Araghizadeh F,Minocha A,Abell TL

    更新日期：2006-09-01 00:00:00

  • Cost-effectiveness of the 21-gene breast cancer assay in Mexico.

    abstract：INTRODUCTION:The 21-gene breast cancer assay (Oncotype DX(®); Genomic Health, Inc.) is a validated diagnostic test that predicts the likelihood of adjuvant chemotherapy benefit and 10-year risk of distant recurrence in patients with hormone-receptor-positive, human epidermal growth receptor 2-negative, early-stage brea...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-015-0190-8

    authors： Bargalló-Rocha JE,Lara-Medina F,Pérez-Sánchez V,Vázquez-Romo R,Villarreal-Garza C,Martínez-Said H,Shaw-Dulin RJ,Mohar-Betancourt A,Hunt B,Plun-Favreau J,Valentine WJ

    更新日期：2015-03-01 00:00:00

  • Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape.

    abstract：:As head and neck squamous cell carcinoma (HNSCC) patients with distant metastases (DM) were generally treated only palliatively, the value of screening for DM was usually limited to attempts to avoid extensive locoregional treatment when DM were present pretreatment. Recently, the concept of treating oligometastases, ...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/s12325-018-0662-8

    authors： de Bree R,Senft A,Coca-Pelaz A,Kowalski L,Lopez F,Mendenhall W,Quer M,Rinaldo A,Shaha AR,Strojan P,Takes RP,Silver CE,Leemans CR,Ferlito A

    更新日期：2018-02-01 00:00:00

  • Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review.

    abstract：:Atrial fibrillation (AF) and venous thromboembolism (VTE) are highly prevalent and relevant healthcare issues. Direct oral anticoagulants (DOACs) are now the first-choice for anticoagulant treatment of these conditions displaying a better efficacy/safety profile than vitamin-K antagonists, mainly due to significantly ...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/s12325-020-01307-z

    authors： Ballestri S,Capitelli M,Fontana MC,Arioli D,Romagnoli E,Graziosi C,Lonardo A,Marietta M,Dentali F,Cioni G

    更新日期：2020-05-01 00:00:00

  • Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn's Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States.

    abstract：INTRODUCTION:Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. This real-world study evaluated persistence, dose titration, health care resource utilization (HCRU) and associated costs, and medication use among CD patients treated with ustekinumab (UST) in several pooled US commercia...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-020-01276-3

    authors： Obando C,Ding Z,Muser E,Vaidya N,Qiang W,Sun X,Wang H,Mallampati R,Xie L

    更新日期：2020-05-01 00:00:00

  • Meta-Analysis of Regorafenib-Associated Adverse Events and Their Management in Colorectal and Gastrointestinal Stromal Cancers.

    abstract：INTRODUCTION:To assess the risk factors associated with regorafenib-related adverse events (AEs) in metastatic colorectal cancer (mCRC) and gastrointestinal stromal tumors (GIST). We also evaluated different measures of combatting AEs and their success rate to aid physicians in early identification and management of re...

    journal_title：Advances in therapy

    pub_type： 杂志文章,meta分析

    doi：10.1007/s12325-019-01013-5

    authors： Xie G,Gong Y,Wu S,Li C,Yu S,Wang Z,Chen J,Zhao Q,Li J,Liang H

    更新日期：2019-08-01 00:00:00

  • Susceptibility to various oral antiseptics of Porphyromonas gingivalis W83 within a biofilm.

    abstract：:The origin of chronic periodontal disease is strongly related to the nature and physiology of the subgingival bacterial biofilm, of which Porphyromonas gingivalis is a main protagonist. This study was conducted in vitro, to test the susceptibility of the W83 strain of P gingivalis to several oral antiseptics, bearing ...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/BF02877764

    authors： Bercy P,Lasserre J

    更新日期：2007-11-01 00:00:00

  • The Association Between Switching from Synthroid® and Clinical Outcomes: US Evidence from a Retrospective Database Analysis.

    abstract：INTRODUCTION:Clinical guidelines recommend levothyroxine as the standard of care for hypothyroidism and that patients should be treated with a consistent preparation of synthetic levothyroxine without switching among formulations. This study examines the likelihoods of negative clinical outcomes between continuous user...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-020-01537-1

    authors： Hennessey JV,Espaillat R,Duan Y,Soni-Brahmbhatt S,Lage MJ,Singer P

    更新日期：2020-10-28 00:00:00

  • A review of uric acid, crystal deposition disease, and gout.

    abstract：:There has been increased interest in gout in both academic and clinical practice settings. Several reasons may explain this. The prevalence of both hyperuricemia and gout has risen in the last decades in developed countries and therefore the burden of gout has increased. The association of hyperuricemia and gout with ...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/s12325-014-0175-z

    authors： Perez-Ruiz F,Dalbeth N,Bardin T

    更新日期：2015-01-01 00:00:00

  • Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study.

    abstract：INTRODUCTION:Diabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes and has been associated with cardiovascular disease, the leading cause of mortality in diabetes. As asymptomatic myocardial ischemia (MI) is frequent in diabetes, we hypothesized that DPN may be associated with MI in p...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-016-0399-1

    authors： Baltzis D,Roustit M,Grammatikopoulou MG,Katsaboukas D,Athanasiou V,Iakovou I,Veves A,Manes C,Trakatelli MC

    更新日期：2016-10-01 00:00:00

  • Correction to: Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease.

    abstract：:In the original article. The third author name is incorrect. The correct name is Nicholas J. Leeper. ...

    journal_title：Advances in therapy

    pub_type： 已发布勘误

    doi：10.1007/s12325-020-01220-5

    authors： Berger A,Simpson A,Leeper NJ,Murphy B,Nordstrom B,Ting W,Zhao Q,Berger J

    更新日期：2020-02-01 00:00:00

  • Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs.

    abstract：INTRODUCTION:Endometriosis symptoms are nonspecific and overlap with other gynecologic and gastrointestinal diseases, leading to long diagnostic delays. The burden of endometriosis has been documented; however, little is known about the impact of diagnostic delays on healthcare costs leading up to diagnoses. The purpos...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-019-01215-x

    authors： Surrey E,Soliman AM,Trenz H,Blauer-Peterson C,Sluis A

    更新日期：2020-03-01 00:00:00

  • 72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.

    abstract：INTRODUCTION:The long-term safety of dimethyl fumarate (DMF) in patients with relapsing-remitting multiple sclerosis (RRMS) has been studied in mainly Caucasian patients. The present interim analysis aimed to evaluate the 72-week safety of DMF in Japanese patients with RRMS. METHODS:Safety data of Japanese subjects en...

    journal_title：Advances in therapy

    pub_type： 杂志文章,随机对照试验

    doi：10.1007/s12325-018-0788-8

    authors： Ochi H,Niino M,Onizuka Y,Hiramatsu K,Hase M,Yun J,Matta A,Torii S

    更新日期：2018-10-01 00:00:00

  • Genital infection with human papillomavirus in adolescents.

    abstract：:Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections in adolescents. Such infection is associated with substantial health risks and is unpredictable in its resolution. Genital warts are the most common clinical manifestations of genital HPV infections. Most genital warts are c...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/BF02849928

    authors： Leung AK,Kellner JD,Davies HD

    更新日期：2005-05-01 00:00:00

  • Pharmacokinetics and Safety of DS-8500a, an Antidiabetic Drug, in Japanese Subjects with Hepatic or Renal Impairment: A Single-Center, Open-Label, Single-Dose Study.

    abstract：INTRODUCTION:The pharmacokinetics, safety, and tolerability of DS-8500a (a G protein receptor 119 agonist) up to 100 mg have been investigated in healthy Japanese adults. The objective of this study was to evaluate the effects of hepatic or renal impairment on the pharmacokinetics of a single 25-mg oral dose of DS-8500...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-018-0739-4

    authors： Kato M,Ishizuka H,Taguchi T,Shiosakai K,Kamiyama E,Sata M,Yoshida T

    更新日期：2018-08-01 00:00:00

  • A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma.

    abstract：:This multicenter, randomized, double-blind clinical trial was undertaken to compare the intraocular pressure (IOP)-lowering efficacy and safety of topical bimatoprost 0.03% with that of latanoprost 0.005% for the treatment of patients with normal-tension glaucoma. After washout of all ocular hypotensive medications, p...

    journal_title：Advances in therapy

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1007/BF02850159

    authors： Dirks MS,Noecker RJ,Earl M,Roh S,Silverstein SM,Williams RD

    更新日期：2006-05-01 00:00:00

  • Two innovative pharmaceutical forms of leuprorelin: results from 818 patients with advanced prostate cancer.

    abstract：OBJECTIVES:This study set out to examine the efficacy and tolerability of two innovative implant forms of leuprorelin acetate in men with advanced hormone-dependent prostate cancer in everyday clinical practice. METHODS:Data were collected from 818 patients (from 273 centers across Germany) who were pretreated with sl...

    journal_title：Advances in therapy

    pub_type： 杂志文章

    doi：10.1007/s12325-013-0010-y

    authors： Gravel P,Samland D,Löffler M,Maier S,Panozzo M,Muenzberg M

    更新日期：2013-03-01 00:00:00

  • Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.

    abstract：INTRODUCTION:An 8-week trial of amlodipine/valsartan/hydrochlorothiazide (Aml/Val/HCTZ) for moderate or severe hypertension demonstrated more-pronounced blood pressure (BP)-lowering effects compared with dual-component therapies. To elucidate the effects of time and baseline BP on the observed responses, exploratory an...

    journal_title：Advances in therapy

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1007/s12325-009-0077-7

    authors： Calhoun DA,Crikelair NA,Yen J,Glazer RD

    更新日期：2009-11-01 00:00:00

  • Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review.

    abstract：:In the original article, under the "Access to treatment" heading. ...

    journal_title：Advances in therapy

    pub_type： 已发布勘误

    doi：10.1007/s12325-020-01488-7

    authors： Rezk MF,Pieper B

    更新日期：2020-11-01 00:00:00

  • X-Linked Hypophosphataemic Rickets and Growth.

    abstract：:X-linked hypophosphataemia (XLH) is the most prevalent form of hereditary rickets characterized by an alteration of phosphate metabolism which frequently leads to the appearance of fractures, bone deformities and growth delay. Although the mechanism of growth impairment in patients with XLH still needs to be clarified...

    journal_title：Advances in therapy

    pub_type： 杂志文章,评审

    doi：10.1007/s12325-019-01178-z

    authors： Santos Rodríguez F

    更新日期：2020-05-01 00:00:00

  • Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.

    abstract：PURPOSE:To compare the efficacy of bromfenac 0.09% and dexamethasone 0.1% in the treatment of anterior chamber inflammation after uncomplicated cataract surgery. METHODS:Seventy-six patients with senile cataracts and no other ocular comorbidities who underwent uneventful phacoemulsification were randomized 1:1 to rece...

    journal_title：Advances in therapy

    pub_type： 杂志文章,随机对照试验

    doi：10.1007/s12325-019-01076-4

    authors： Coassin M,De Maria M,Mastrofilippo V,Braglia L,Cimino L,Sartori A,Fontana L

    更新日期：2019-10-01 00:00:00